ARDDS

We're thrilled to announce that ARDDS will be at the upcoming SNMMI annual convention in Chicago from June 24-27! This is a fantastic opportunity for us to connect with others in the nuclear medicine industry and showcase our cutting-edge technology for dose drawing. We'll be sharing more about our innovative solution for enhancing accuracy, efficiency, and radiation safety in nuclear medicine, so be sure to stop by our booth (BOOTH 1023) to learn more! We can't wait to meet new faces and catch up with old friends at this exciting event. See you in Chicago!

We were recently asked, "How is ARDDS addressing social challenges in the broader community?"

Here is a response from Troy Curnutt, who is a the CEO and visionary leader behind ARDDS.

"As a product focused on enhancing the safety and efficiency of the nuclear medicine industry, ARDDS is indirectly addressing social issues related to public health and safety. By streamlining the dose drawing process, ARDDS helps to ensure accurate and precise doses of radiopharmaceuticals for patients, reducing the potential for errors or miscalculations that could have negative health consequences. Additionally, by reducing radiation exposure and supporting the ALARA principle, ARDDS is helping to minimize the risks associated with nuclear medicine procedures, benefiting both patients and healthcare professionals. By promoting the adoption of innovative technology in the nuclear medicine industry, ARDDS is also contributing to the broader goal of advancing healthcare and improving patient outcomes."